64 related articles for article (PubMed ID: 29651702)
21. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
[TBL] [Abstract][Full Text] [Related]
22. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
[TBL] [Abstract][Full Text] [Related]
23. Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model.
Ichimura-Shimizu M; Kageyama T; Oya T; Ogawa H; Matsumoto M; Sumida S; Kakimoto T; Miyakami Y; Nagatomo R; Inoue K; Cheng C; Tsuneyama K
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884650
[TBL] [Abstract][Full Text] [Related]
24. Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis.
Akiyama K; Warabi E; Okada K; Yanagawa T; Ishii T; Kose K; Tokushige K; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Ariizumi SI; Yamamoto M; Shoda J
Exp Anim; 2018 May; 67(2):201-218. PubMed ID: 29276215
[TBL] [Abstract][Full Text] [Related]
25. Animal models for analyzing metabolic syndrome-associated liver diseases.
Tsuneyama K; Nishitsuji K; Matsumoto M; Kobayashi T; Morimoto Y; Tsunematsu T; Ogawa H
Pathol Int; 2017 Nov; 67(11):539-546. PubMed ID: 29027308
[TBL] [Abstract][Full Text] [Related]
26. Targeting Hepatocellular Carcinoma: What did we Discover so Far?
Brito AF; Abrantes AM; Tralhão JG; Botelho MF
Oncol Rev; 2016 Oct; 10(2):302. PubMed ID: 27994769
[TBL] [Abstract][Full Text] [Related]
27. High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats.
Bingül İ; Aydın AF; Başaran-Küçükgergin C; Doğan-Ekici I; Çoban J; Doğru-Abbasoğlu S; Uysal M
Int Immunopharmacol; 2016 Oct; 39():199-207. PubMed ID: 27494683
[TBL] [Abstract][Full Text] [Related]
28. Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse).
Takahashi T; Nishida T; Baba H; Hatta H; Imura J; Sutoh M; Toyohara S; Hokao R; Watanabe S; Ogawa H; Uehara H; Tsuneyama K
Mol Clin Oncol; 2016 Aug; 5(2):267-270. PubMed ID: 27446562
[TBL] [Abstract][Full Text] [Related]
29. The promise of metabolic phenotyping in gastroenterology and hepatology.
Holmes E; Wijeyesekera A; Taylor-Robinson SD; Nicholson JK
Nat Rev Gastroenterol Hepatol; 2015 Aug; 12(8):458-71. PubMed ID: 26194948
[TBL] [Abstract][Full Text] [Related]
30. A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma.
Zhang W; Zhou L; Yin P; Wang J; Lu X; Wang X; Chen J; Lin X; Xu G
Sci Rep; 2015 Mar; 5():8984. PubMed ID: 25757957
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome and risk of cancer: which link?
Mendonça FM; de Sousa FR; Barbosa AL; Martins SC; Araújo RL; Soares R; Abreu C
Metabolism; 2015 Feb; 64(2):182-9. PubMed ID: 25456095
[TBL] [Abstract][Full Text] [Related]
32. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.
Lozano E; Sanchez-Vicente L; Monte MJ; Herraez E; Briz O; Banales JM; Marin JJ; Macias RI
Mol Cancer Res; 2014 Jan; 12(1):91-100. PubMed ID: 24255171
[TBL] [Abstract][Full Text] [Related]
33. Oncometabolomics in cancer research.
Gupta S; Chawla K
Expert Rev Proteomics; 2013 Aug; 10(4):325-36. PubMed ID: 23992416
[TBL] [Abstract][Full Text] [Related]
34. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
[TBL] [Abstract][Full Text] [Related]
35. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
Yoshimoto S; Loo TM; Atarashi K; Kanda H; Sato S; Oyadomari S; Iwakura Y; Oshima K; Morita H; Hattori M; Honda K; Ishikawa Y; Hara E; Ohtani N
Nature; 2013 Jul; 499(7456):97-101. PubMed ID: 23803760
[TBL] [Abstract][Full Text] [Related]
36. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.
Fujii M; Shibazaki Y; Wakamatsu K; Honda Y; Kawauchi Y; Suzuki K; Arumugam S; Watanabe K; Ichida T; Asakura H; Yoneyama H
Med Mol Morphol; 2013 Sep; 46(3):141-52. PubMed ID: 23430399
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome.
Nishida T; Tsuneyama K; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Nakanishi Y; Sasaki Y; Suzuki W; Iizuka S; Nagata M; Shimada T; Aburada M; Shimada Y; Imura J
Lab Invest; 2013 Feb; 93(2):230-41. PubMed ID: 23212097
[TBL] [Abstract][Full Text] [Related]
38. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
Wang X; Zhang A; Sun H
Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
[TBL] [Abstract][Full Text] [Related]
39. Bile acids: from digestion to cancers.
Baptissart M; Vega A; Maqdasy S; Caira F; Baron S; Lobaccaro JM; Volle DH
Biochimie; 2013 Mar; 95(3):504-17. PubMed ID: 22766017
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
